454 Life Sciences news from FierceBiotech
NewsPerlegen, 454 to study drug response
Perlegen Sciences and 454 Life Sciences (now owned by Roche) have teamed up to conduct large scale genetic re-sequencing Read more...
| Press ReleasesPRESS RELEASE: Perlegen and 454 to Collaborate in Drug Response Sequencing Study Perlegen and 454 to Collaborate in Drug Response Sequencing Study Novel Study Design Tests New Pharmacogenomic Approach MOUNTAIN VIEW, Calif. & BRANFORD, Conn. -- Perlegen Sciences and 454 Life Read more... |
Get more 454 Life Sciences coverage at:
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends